IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL

Clinical trial NCT05136924 · UNKNOWN

Trial details

NCT number: NCT05136924
Sponsor: Vance Thompson Vision - MT
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2021-12-01
Primary completion: 2022-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.